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Abstract not received. 
Antibodies against synthetic peptides representing the class-II antigen HLA-DR and -DQ /l chain N-termi- 
nal sequences were prepared in rabbits. The two octapeptides only share two amino acids and enzyme-linked 
immuno-assays howed the antisera only to bind to its own antigen. Both peptide antisera detected a 29 
kDa component in immunoblots of Raji and AL-34 cell plasma membrane proteins separated by SDS gel 
electrophoresis. The binding of either N-terminal peptide antiserum was selectively inhibited only by the 
peptide used as antigen. Indirect immunofluorescence.analysis by flow cytofluorometry showed specific sur- 
face immunofluorescence in 1: 100-l : loo0 dilutions in lymphoblastoid and blood mononucleated cells. In 
the latter the binding was primarily confined to monocytes and a subpopulation of lymphocytes. It is con- 
cluded that locus-specific immunological reagents to distinguish between fi chains of HLA-DR and -DQ 
have been prepared by the preparation by the production of antibodies against the N-terminal sequences 
of each polypeptide 
HLA class II antigen Flow cytofuorometry ELISA Immunoblotting 
1. INTRODUCTION 
HLA class II antigens are structurally closely 
related, highly polymorphic, heterodimeric pro- 
teins consisting of an CY chain (Mr 35000) and a p 
chain (Mr 29000) [1,2]. The class II antigens are 
primarily expressed on the surface of cells impor- 
tant to the immune response [3]. The genes en- 
coding for these antigens are part of the major 
histocompatibility complex (MHC) located on the 
short arm of chromosome 6. Serologic studies in- 
dicate the existence of at least 3 distinct loci, DP, 
DQ, and DR [3], and more recent molecular clon- 
ing studies have revealed the presence of several cz 
and ,8 chain genes at each locus [4]. 
Little is known about the differences in expres- 
sion and function of these different gene loci. 
These problems are difficult to investigate and re- 
quire immunologic reagents able to distinguish 
products of the different loci, as well as the 
subspecificities due to allelic variation within one 
locus. The extensive sequence homology between 
all the class II antigens makes it difficult to obtain 
monospecific antibodies [5-71. We have therefore 
used antibodies against synthetic peptides 
representing different parts of HLA class II ,8 
chains to detect binding to the surface of immune 
competent cells. Antibodies to synthetic in- 
tramolecular amino acid sequences are successfully 
employed to obtain antibodies with a predeter- 
mined specificity against a variety of antigens [S]. 
Such antibodies may even detect variation in se- 
quences contained within large homologous but 
polymorphic polypeptides, such as the rat thy-l 
[9], and human MHC Class I [lo] and Class II 
[11,12] antigens. The advantage of this technique 
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is that antibodies can be produced against proteins 
not yet isolated and purified, but predicted from 
the nucleotide sequence of cloned genes whether 
genomic or complementary to mRNA molecules. 
Analysis of published amino acid sequences of 
HLA class II ,& chains obtained from protein se- 
quencing [13], or predicted from cloned genomic 
or cDNA [5-7,14,15] revealed the N-terminal se- 
quences of DQ and DR ,f3 chains to be highly con- 
served for each locus. Since only 2 out of the first 
8 amino acids are shared, we chose these 2 oc- 
tapeptides to produce locus specific antisera to 
detect binding of HLA-DQ and -DR fl chains on 
the surface of living cells. Our results demonstrate 
that rabbit antisera against either peptide bound to 
the surface of living cells and detected a compo- 
nent of Mr 29000 by immunoblotting [16] of 
denatured components in plasma membrane 
preparations of cells known to express Class II 
antigens. 
2. MATERIALS AND METHODS 
2.1. Cells 
The lymphoblastoid cell lines Raji and AL-34, 
established following EBV transformation of lym- 
phocytes from an HLA-DR 3/4 positive patient 
with insulin-dependent diabetes by H. Vissing, 
were cultured in RPM1 1640 medium containing 
10% (v/v) fetal calf serum. Human peripheral 
blood mononuclear cells were isolated by Ficoll- 
Paque density centrifugation [17] from blood 
donated by healthy volunteers, or recently 
diagnosed insulin-dependent (type 1) diabetic pa- 
tients in good metabolic control. 
2.2. Peptides and immunization 
The peptides DQ(l-8) and DR( 1-8) (table 1) 
represent the N-terminal amino acid sequences 
shown [5-7,13-151 to be common to DQ and DR 
,f3 chains, respectively. Both peptides were syn- 
thesized by Cambridge Res. Biochem. Ltd, Cam- 
bridge, England and the sequence confirmed by se- 
quence analysis (Gas Microsequenator, Applied 
Biosystems, Foster City, CA). The peptides were 
coupled to porcine thyroglobulin (PTG) (Sigma, 
St. Louis, MO) using difluorodinitrobenzene [181. 
New Zealand white rabbits were injected in- 
tracutaneously at multiple sites with 1 mg antigen 
in complete Freund’s adjuvant, and then given 3 
booster injections every other week with 0.5 mg in 
incomplete Freund’s adjuvant, and then at 
monthly intervals. Blood was sampled 5-7 days 
after each booster injection. 
2.3. ELBA 
Microtiter plates (NUNC, Roskilde, Denmark) 
were coated with 2 pg/well of peptides DQ( l-8) 
and DR(l-8), respectively, and blocked with 
0.01% (w/v) bovine insulin in phosphate-buffered 
saline (PBS). Sera were diluted (1: 1000-l : 50000) 
in PBS containing 0.01% insulin and 0.05% 
Tween 20. The plates were incubated at 37°C for 
2 h first with rabbit serum and then with an f(ab)z 
goat anti-rabbit immunoglobulin-peroxidase con- 
jugate (Tago, Burlingame, CA) second antibody, 
diluted 1: 2500 in PBS with insulin and Tween. The 
plates were washed 3 times in PBS containing in- 
sulin and in distilled water, respectively, prior to 
and after incubation with the second antibody. 
Peroxidase activity was detected at room 
temperature with 0.4 g/l o-phenylenediamine 
(Sigma) and 0.03% hydrogen peroxide in 50 mM 
citrate-phosphate (pH 5.0). The absorbance at 
490 nm, automatically subtracted with that at 
600 nm, was read on an ELISA reader (Dynatech, 
Alexandria, VA). A standard antiserum for each 
peptide was analyzed, diluted 1: 5000, on each 
Table 1 
HLA Carrier Sequence Rabbit 
antigen no. 
DQ(l-8) PTG -Arg-Asp-Ser-Pro-Glu-Asp-Phe-Val 1828,1829 
DR(l-9) PTG -Gly-Asp-Thr-Arg-Pro-Arg-Phe-Leu 1789,179O 
HLA-DQ and -DR N-terminal sequences were synthesized and 
coupled to porcine thyroglobulin (PTG) with the N-terminal reagent 
difluorodinitrobenzene 
330 
Volume 189, number 2 FEBS LETTERS September 1985 
plate to correct for interassay variation. Results 
are expressed as absorption at 490 nm. Non- 
specific binding to non-coated wells was 
subtracted. 
2.4. Flow cytofluorometry on living cells 
Cells were washed once and resuspended in PBS 
containing 1% BSA and 5 mM sodium azide 
(PBS/BSA/NaNs buffer). Rabbit antisera were 
also diluted in this type of medium and incubated 
for 1 h at 4°C with 0.5 x lo6 cells per tube in a 
final volume of 0.2 ml. The cells were washed by 
centrifugation (150 x g, 5 min) in 2.5 ml buffer 
and resuspended gently in 0.1 ml FITC-labelled 
goat anti-rabbit immunoglobulin serum (Tago, 
Burlingame, CA) diluted 1: 40 in PBS/BSA/NaN3 
buffer. After 45 min at 4°C in the dark the cells 
were washed as before and then fixed in 1% 
paraformaldehyde in PBS/BSA/NaNj. Finally, 
the cells were washed, resuspended in 0.5 ml 
PBS/BSA/NaNs and kept at 4°C in the dark until 
fluorescence was analysed in a FACS IV (Becton 
Dickinson, Mountain View, CA) flow cytometer. 
Results are given as mean fluorescence intensity 
per cell, relative to the autofluorescence of 
glutaraldehyde fixed chicken red blood cells as a 
standard, in percent of the fluorescence obtained 
with normal rabbit serum, and as the increase of 
fluorescence peak channel number. 
2.5. Immunoblotting 
Plasma membrane nriched preparations of Raji 
and AL 34 cells, obtained as described [19] were 
denatured by boiling for 3 min in 3% SDS and 5% 
,&mercaptoethanol and subjected to gel elec- 
trophoresis on 10% polyacrylamide slab gels [20]. 
Molecular mass standards were analyzed on the 
same gel. The proteins were electroblotted onto 
nitrocellulose filters (BA 85, Schleicher and 
Schuell, Dassel, FRG) which were treated with 2% 
gelatine in 50 mM Tris-saline (pH 7.4) containing 
0.05% Tween 20 and kept at -20°C until an- 
tibody binding was tested. The part of the filter 
containing the molecular mass standards was 
stained with fast green. Filter strips were incubated 
for 1 h at room temperature in rabbit sera or with 
a mouse monoclonal antibody against HLA-DR ,f3 
chain (DAKO, Copenhagen), all diluted 1: 100 in 
Tris-saline containing 0.2% gelatine and 0.05% 
Tween 20. The strips were washed in Tris-saline 
with 0.05% Tween 20 and incubated with a 
peroxidase-labelled second antibody, either swine 
anti-rabbit immunoglobulin serum (DAKO) or 
anti-mouse immunoglobulin serum (DAKO), 
followed by washing and staining with 0.5 g/l 
4-chloro-1-naphthol (Merck, Darmstadt) and 
0.01% hydrogen peroxide as substrates in 50 mM 
sodium acetate buffer (pH 5.5). Antisera were ab- 
sorbed with the synthetic peptides by incubation at 
4°C overnight with undiluted sera to which the 
respective peptides, dissolved in distilled water, 
had bien added (1: 10, v/v). Absorbed sera were 
diluted 1: 1oL) in Tris-saline immediately before 
immunoblotting . 
2.6. Isolation of IgG on protein A-Sepharose 
Rabbit serum (1 ml) was applied to a column 
packed with 1 ml protein A-Sepharose 4 B (Phar- 
macia, Uppsala) equilibrated in PBS. The column 
was washed with at least 5 vols PBS, IgG eluted 
with 0.05 M glycine buffer (pH 3.0) and 0.5 ml 
fractions collected in test tubes containing 20 /cl of 
1 M Tris for immediate neutralization. Fractions 
containing protein were pooled, dialysed overnight 
at 4°C against PBS, and tested for anti-peptide an- 
tibodies in the ELISA test. 
3. RESULTS 
3.1. Production of peptide specific antibodies 
Analysis by ELISA (fig.1) showed that im- 
munization with the PTG coupled peptides 
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Fig.1. ELISA of rabbit sera from animals immunized 
with PTG-coupled peptides DQ(l-8) (no.1828, l ; 
no.1829, 0), and DR(l-83 (no.1789, q ; no.1790, n ) 
respectively on microtiter plates coated with DQ(l-8) 
(panel a), and DR(l-8) (panel b), respectively. Sera 
tested were obtained after the 4th booster injection. 
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Fig.2. Immunoblotting of plasma membrane enriched preparations from the cell lines Raji (panel a) and AL-34 (panel 
b), incubated with a mouse monoclonal anti HLA-DR fi chain (DAKO) (lane A), normal rabbit sera (B), anti DQ(l-S), 
no.1828 (C) and no.1829 (D), anti DR(l-8), no.1789 (E) and no.1790 (F), lanes G and H show incubation with IgG 
from sera nos 1829 and 1790, respectively, purified on protein A-Sepharose. For details see section 2. 
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Fig.3. Inhibition of antiserum binding to AL-34 membrane preparation by preincubation with free peptide. Filter strips 
were incubated with antisera from rabbit no. 1829 (anti DQ(l-S), panel a, pretreated overnight with saline (lane l), 
peptide DQ(l-8) at a final concentration of 0.1, 1 .O and 5.0 mg/ml, respectively (lanes 2-4, respectively), and peptide 
DR(l-8), at 5.0 mg/ml, respectively (lane 5). Panel b shows filter strips incubated with antisera from rabbit no.1790 
(anti DR(l-8)) pretreated overnight with saline (lane l), peptide DQ(l-8) at 5 mg/ml (lane 2) and peptide DR(l-8) 
at 0.1, 1.0 and 5.0 mg/ml, respectively (lanes 3-5). Final dilution of rabbit sera was 1: 100, for details see section 2. 
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resulted in antibodies recognizing specifically the 
amino acid sequence of the 2 different peptides. A 
maximal titer was usually obtained after 3 booster 
injections and remained constant for several 
months (not shown). Pre-immune sera as well as 
sera from animals immunized with PTG alone did 
not bind to peptide coated plates. There was no 
cross-reactivity detected when each antiserum was 
tested at various dilutions on plates coated with the 
other peptide (not shown). AI1 antisera showed 
high titers, often greater than 1: 104, of PTG an- 
tibodies when tested on PTG coated plates (not 
shown). 
3.2. Detection of 29 kDa proteins 
DQ( l-8) and DR( l-8) peptide antisera detected 
29 kDa components in immunoblots of Raji and 
AL-34 cell plasma membrane proteins separated 
by SDS-gel electrophoresis (fig.2). Each peptide 
was used to immunize 2 rabbits, and only one, 
no. 1828, immunized with DQ(l-8), was not reac- 
tive with this band. The HLA-DR monoclonal an- 
tibody also detected a 29 kDa component (fig.2). 
The binding of either N-terminal peptide an- 
tiserum was selectively inhibited in a dose- 
dependent manner only by the peptide which was 
used as antigen (fig.3). Protein A-Sepharose 
purified IgG bound to a component of similar size 
allowing detection of the 29 kDa component dur- 
ing the condition of a reduced background (fig.2). 
3.3. Surface binding of peptide antisera 
The antisera to both N-terminal peptides bound 
to the surface of Raji and AL-34 cells known to ex- 
press both HLA-DR and -DQ antigens (table 2). 
The cell surface immunofluorescence showed a 
ring-shaped to dotted appearance and in ex- 
periments separate from those shown in table 2, 
immunofluorescence was discernible by both 
microscopy and flow cytofluorometry in dilutions 
ranging from 1: 100 to 1: 1000. When tested on 
human peripheral blood mononuclear cells, the an- 
Table 2 
Flow cytometric analysis of rabbit antigen binding to living cells 
Expt 
no. 
Relative fluorescence Peak fluorescence channel number 
Individual Individual 
NRS 1828 1829 1789 1790 NRS 1828 1829 1789 1790 
(%) 
Raji 1 
2 
3 
4 
5 
AL-34 1 
2 
3 
Human peripheral 1 
blood MC 2 
3 
4 
5 
100 
100 
100 
100 
100 
100 
100 
114 100 100 133 0 4 0 0 38 
115 147 109 308 0 3 21 4 48 
121 128 106 174 0 5 8 3 17 
108 119 126 192 0 3 7 12 16 
111 117 102 154 0 13 11 13 28 
250 433 375 283 0 15 35 42 24 
100 133 143 161 0 0 6 4 21 
111 106 110 143 0 21 0 0 34 
128 147 nd nd 0 13 20 nd nd 
140 139 135 176 0 16 16 12 19 
140 138 154 170 0 14 10 12 19 
151 120 129 134 0 23 13 16 21 
138 120 109 141 0 17 25 23 23 
Cells (0.5 x 106/tube) were incubated with rabbit sera (final dilution 1: 100) and FITC-conjugated goat anti-rabbit 
immunoglobulin sera, as described in section 2, and analysed in the FACS IV. Results are expressed as mean 
fluorescence intensity per cell, calculated based on the autofluorescence of glutaraldehyde-fixed chicken red blood cells 
( = 1 .O), and expressed as percent of the value obtained with NRS ( = lOO%), or as increase in fluorescence p ak channel 
number (l-255) based on NRS (= 0), and corrected for the fluorescence peak of chicken red blood cells (= 100). All 
samples were run in duplicates, and 10000 cells were analysed per sample 
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Fig.4. Flow cytometric analysis of antisera binding to human peripheral blood mononuclear cells. Panel A shows a 
typical result for forward light scatter (FLS) and FITC fluorescence. Pointers indicate monocyte gating in FLS. Panel 
B shows dual parameter analysis of the same sample. For details see section 2. 
tisera bound primarily to cells defined by forward 
light scatter to belong to larger cells which are con- 
sistent with the population of monocytes, and a 
subpopulation of lymphocytes (fig.4). The binding 
of the peptide antisera showed a similar intensity, 
however, antiserum no. 1828 showed little binding. 
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4. DISCUSSION 
A variety of parameters have been claimed to be 
of importance when chasing a peptide sequence for 
antibody production. Among these, hydrophilicity 
and probability of certain characteristics to deter- 
mine secondary structure have been claimed to 
determine the ability of a given peptide to elicit an- 
tibody binding to the same sequence in a protein 
[8,9,21,22]. Also, a peptide length of around 14 
amino acids was thought to be necessary to pro- 
duce specific antibodies [21]. However, the present 
study demonstrates that these constraints are not 
always applicable, nor necessary. First, we used 
the peptide antibody technique to make antibodies 
against a given part of a polypeptide sequence, 
determined rather by its uniqueness than its 
hydrophilicity or amino acid composition. The im- 
portant test was to determine whether it was possi- 
ble to make antibodies against the N-terminal se- 
quences of the HLA-DQ and -DR p chains, respec- 
tively. Such antibodies would be useful as markers 
of a given subgroup of the family of HLA-D 
region proteins. In the case of these HLA class II 
antigens, the regions of interest are rather short, 
and inclusion of longer stretches of homologous 
sequences would increase the risk of obtaining 
cross-reactive antisera. The peptides chosen by us 
(table 1) were therefore by necessity selected 
primarily due to their uniqueness of sequence, and 
both peptides are only 8 amino acids long. 
class II positive transformed cells kept as con- 
tinuous cell lines. In addition, and more impor- 
tantly, the antisera also bound to the monocyte 
and only part of the lymphocyte subpopulation of 
human peripheral blood cells. Experiments with 
double fluorescence showed no binding to T- 
lymphocytes as defined by binding of the 
monoclonal antibody Leu 1 (Beckton and Dickin- 
son), which normally do not express class II an- 
tigens (not shown). The absence of binding to T- 
lymphocytes is a useful negative control with 
respect to the specificity of our antisera. 
Yet, both peptides elicited production of an- 
tibodies which by the ELISA test proved to be se- 
quence specific as they did not cross-react with 
each other. Antisera against both peptides also 
bound to a protein species of Mr 29000. The com- 
ponents detected corresponded to that recognized 
by the monoclonal HLA class II fl chain antibody. 
Although DQ and DR fl chains cannot be 
distinguished by one-dimensional SDS-gel elec- 
trophoretic analysis and the lack of proof that 
both antisera do not detect he same molecule, our 
finding that there was a selective inhibition of 
binding only by the peptide used for immunization 
excludes the possibility of non-specific cross- 
reactivity. Our results are consistent with the 
possibility that 2 structurally distinct proteins of 
the same apparent molecular mass were detected. 
Binding to living cells has so far been 
demonstrated only in peptide antibodies against 
the mouse thy-l antigens [9], and more recently 
against HLA-DR fl chains [ 121. The latter peptides 
were, however, chosen from a hydrophilic part of 
the molecule showing extensive homology with 
other DR and DQ polypeptides. These antisera 
would therefore not be locus specific. The same 
limitation would also be true for the study using 
14-16-mer peptides to produce antibodies against 
HLA-DR fl chains [ 111. These antibodies showed 
reactivity with denatured proteins on im- 
munoblots, but not surface binding to living cells. 
In contrast o these studies, our antisera are unique 
since they, despite being raised against peptides of 
only 8 amino acids in length, bind to their respec- 
tive target proteins both in the native and 
denatured state. We therefore conclude that the 2 
sets of antisera should be useful as specific im- 
munological reagents to detect expression of p 
chain genes in the HLA-DQ and -DR loci. 
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